Myriad Genetics, Inc. (MYGN)
3.82
-0.09
(-2.30%)
USD |
NASDAQ |
May 22, 16:00
3.81
-0.01
(-0.26%)
After-Hours: 20:00
Myriad Genetics EPS Diluted (TTM) : -4.316 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Celldex Therapeutics, Inc. | -4.267 |
| Plus Therapeutics, Inc. | -3.267 |
| Perspective Therapeutics, Inc. | -1.396 |
| Atossa Therapeutics, Inc. | -4.370 |
| AVITA Medical, Inc. | -1.570 |